Drugs / DWC202002
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04343547 | Apr → Jul 2020 | — | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWC202002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04343547 ↗ |
| Route | Oral | “Tablets, Oral, multiple doses of DWC202001 and DWC202002 in combination” NCT04343547 ↗ |